Merck's Covid pill hailed after cutting hospitalizations by 50%

21


US pharmaceutical company Merck said Friday it will seek the authorization of its oral drug molnupiravir for Covid-19 after it was shown to reduce the chance newly infected patients were hospitalized by 50 percent.

The post Merck's Covid pill hailed after cutting hospitalizations by 50% appeared first on The Guardian Nigeria News – Nigeria and World News.



Source: Guardian Newspaper